Session Walkthrough

This page describes the shape of a session that takes place in a clinical setting, with a provider present. It is a description, not a protocol. Every clinic runs its own process, and the specifics of eligibility, screening, medication, dosing, route of administration, and monitoring are decisions a clinician makes with you. Nothing here is preparation guidance to follow on your own — if a step matters to you, raise it with your provider.

Before the day

The period before a first session is usually taken up by clinical work rather than anything you do alone: intake paperwork, a review of your medical and psychiatric history, a review of every medication and supplement you take, and a conversation about what the treatment is being used for and what would count as improvement. Clinics differ in how they handle transport, food and drink, and what you may or may not do before arriving; those instructions come from the clinic, and they are the only ones you should follow.

Experiential — Subjective reports or common clinical practice, not a demonstrated therapeutic effect. The specific content of pre-session routines varies by clinic and is not standardized in published guidance.

Arriving

Most people describe arrival as unremarkable and slightly clinical: check-in, a brief conversation with the provider, and baseline observations such as blood pressure. Rooms are commonly set up to be quiet and low-stimulus — a reclining chair or bed, adjustable lighting, and often the option of headphones or an eye mask. Whether those elements are offered, and whether you use them, is a conversation to have with the clinical team.

During administration

Ketamine given at subanesthetic levels in a supervised setting commonly produces dissociative and perceptual effects: a sense of distance from the body, altered perception of time, changed sense of space, and shifts in mood and thinking. These effects have been described in controlled human research since the early 1990s.

Well-established· Krystal et al., Arch Gen Psychiatry, 1994 — Supported by replicated, well-conducted research.

Transient increases in blood pressure and heart rate can occur during and shortly after administration, which is one reason clinical monitoring is part of the treatment rather than an optional extra. The FDA-approved labeling for esketamine nasal spray, the only ketamine-family product approved in the United States for treatment-resistant depression, requires that patients be monitored by a healthcare provider for at least two hours after each dose.

Well-established· FDA SPRAVATO (esketamine) prescribing information and REMS — Supported by replicated, well-conducted research.

Intravenous and intramuscular ketamine used off-label for psychiatric indications are not covered by that labeling, and monitoring periods for those routes are set by the treating clinic rather than by a single national standard.

◇Source pending verification: a consolidated, citable standard for off-label monitoring duration

The difficult parts

Accounts of sessions are not uniformly pleasant. People report anxiety, fear, nausea, confusion, feeling out of control, distressing imagery, and emotional material surfacing without warning. Some describe a session as meaningful and unpleasant at the same time. These reports are consistent enough to take seriously as a normal possibility rather than a failure of the treatment or of the person.

Experiential — Subjective reports or common clinical practice, not a demonstrated therapeutic effect. Drawn from subjective reports and common clinical description, not from a demonstrated therapeutic mechanism.

This is worth planning for with a provider in advance: how you signal distress, who is in the room, what the team does if a session becomes overwhelming, and how the experience is discussed afterward. Those questions are collected in Questions for Your Provider.

Coming down and leaving

The acute effects recede while you are still under observation, and clinics discharge only after their own criteria are met — typically including stable observations and the presence of an accompanying adult. Grogginess, unsteadiness, or lingering emotional intensity after leaving are commonly described. Clinics routinely restrict driving and similar activities for the rest of the day; the exact restriction comes from the clinic.

Experiential — Subjective reports or common clinical practice, not a demonstrated therapeutic effect. Discharge criteria and post-session restrictions are set locally and vary between clinics.

The days after

What people notice in the following days varies widely: nothing, a lift in mood, unusually vivid recall of the session, tiredness, or a low period. Whether and how these after-effects are worked with clinically is covered in Integration. If your mood worsens, or if thoughts of harming yourself appear or intensify, contact your treating clinician and use the crisis resources above.

What this page does not cover

By design, this page contains no dose figures, no instructions about food or fluids before a session, and no self-directed preparation steps. Those are clinical decisions that depend on your history, your medications, and the route of administration, and they belong to the provider who is treating you.

Back to The Experience